Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Innovent Announces NMPA Acceptance of a Supplemental New Drug Application for Sintilimab as Second-Line Therapy for Squamous Non-Small Cell Lung Cancer 2021-01-12 13:02
Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs 2021-01-12 12:26
DarwinHealth Scientists Publish Foundational Research Identifying Regulatory Mechanisms Controlling Cancer Cell States and Drug Response 2021-01-12 08:21
MedSkin Solutions Dr. Suwelack AG Receives FDA 510(k) Clearance for MatriDerm® - Its Three-Dimensional Acellular Collagen Elastin Dermal Matrix Portfolio 2021-01-12 04:38
Happiness Biotech's E-Commerce Business - Happy Buy, Achieved Over 70% Growth in December 2021-01-11 21:00
PharmAbcine announces a research collaboration with LegoChem Biosciences 2021-01-11 21:00
VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China 2021-01-09 11:06
Gracell Biotechnologies Announces Pricing of Initial Public Offering 2021-01-08 14:55
Caprion-HistoGeneX Acquires Clinical Logistics Inc., a Virtual Central Specimen Management CRO, and Expands its Support of Clinical Trials Specimen Logistics 2021-01-07 21:20
Dr David Stamler Appointed CEO 2021-01-07 21:00
Kira Pharmaceuticals Announces $53.5 Million Series B+ Financing to Advance LOGIC Drug Discovery Platform and Pipeline of Complement-targeted Therapies 2021-01-07 20:31
IACTA Pharmaceuticals and Pharmaleads to Develop the World's First Epithelial Protective Drug Harnessing Endogenous Analgesia for the Topical Treatment of Acute and Chronic Ocular Pain 2021-01-07 20:00
VISEN Pharmaceuticals Receives IND Approval to Initiate Phase 2 Clinical Trial of TransCon ™ CNP in Achondroplasia (ACH) in China 2021-01-07 18:45
Merck Acquires AmpTec to Expand mRNA Capabilities for Vaccines, Treatments and Diagnostics 2021-01-07 17:00
Everest Medicines Announces CTA Approval by China NMPA for Phase 3 Trial of Sacituzumab Govitecan-Hziy for Metastatic Urothelial Cancer 2021-01-06 21:54
Everest Medicines Initiates Submission of New Drug Application in Singapore for Sacituzumab Govitecan-Hziy for the Treatment of Metastatic Triple-Negative Breast Cancer 2021-01-06 21:52
VolitionRx Limited Awarded an Additional $4 Million in Non-Dilutive Funding 2021-01-06 21:25
INOVIO's VGX-3100 Demonstrates Positive Phase 2 Efficacy In Treatment of Precancerous Vulvar Dysplasia Caused by HPV-16/18 2021-01-06 21:00
RedHill Biopharma's RHB-204 Granted FDA Fast Track Designation for NTM Disease 2021-01-06 20:24
JOYSBIO's COVID-19 antigen test kit is capable of detecting the new SARS-COV-2 strain found in the United Kingdom and the United States 2021-01-06 15:11
1 262 263 264 265 266 451